# FDA Warning Letter: Exela Pharma Sciences LLC
> 2021-04-27 · Office of Pharmaceutical Quality Operations, Division II · `2331cfaf31aabf04`
## Letter
- **Company:** Exela Pharma Sciences LLC
- **Posted Date:** 2021-04-27
- **Letter Issue Date:** 2021-04-08
- **Issuing Office:** Office of Pharmaceutical Quality Operations, Division II
## Subject
Unapproved New Drug/Compounding/Misbranding
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*